Aspirin Continuation in SLE with Lupus Anticoagulant During Pregnancy
In pregnant patients with SLE and positive lupus anticoagulant, low-dose aspirin should be continued until delivery.
Recommendation Based on Guidelines
The most authoritative guidance comes from multiple high-quality sources that consistently recommend continuation until delivery:
- NICE guidelines recommend 75 mg/day aspirin from 12 weeks until delivery for women with autoimmune disease 1
- ACOG/SMFM guidelines state aspirin should be "continued daily until delivery" in high-risk women, which explicitly includes those with autoimmune disease 2, 3
- The EULAR recommendations for SLE pregnancy management support antithrombotic treatment throughout pregnancy for aPL-positive patients, with continuation protocols aligned with delivery timing 4
Rationale for Continuation Until Delivery
The evidence supporting continuation until delivery is based on several key considerations:
Prevention of Preeclampsia Throughout Pregnancy
Women with SLE and lupus anticoagulant face elevated risk for preeclampsia that persists throughout the entire pregnancy. Aspirin reduces preeclampsia risk by 24% (RR 0.76) when continued appropriately 1. Stopping aspirin prematurely would eliminate this protective effect during the critical third trimester when preeclampsia risk remains substantial.
Thrombotic Risk Management
Lupus anticoagulant positivity confers ongoing thrombotic risk throughout pregnancy and the immediate postpartum period. The EULAR guidelines specifically note that antithrombotic treatment should be maintained according to individual risk profile in aPL-positive patients 4. Your patient's lupus anticoagulant positivity places them in this high-risk category requiring continuous protection.
Evidence from Clinical Trials
The landmark trials (MFMU and CLASP) that established aspirin's efficacy continued aspirin until delivery in most protocols 1. While some trials stopped as early as 35 weeks, the most common and recommended discontinuation point was delivery itself.
Practical Implementation
Dosing: 75-81 mg daily (low-dose aspirin)
Timing considerations:
- Continue through 40 weeks gestation
- Stop only at onset of labor or immediately before planned cesarean delivery
- For scheduled cesarean: discontinue 3-5 days prior only if bleeding risk is deemed excessive by the obstetric team
Important Caveats
Peripartum management: While aspirin should continue until delivery, brief interruption (3-5 days) may be considered immediately before scheduled cesarean section if there are specific bleeding concerns, though this is not routinely necessary with low-dose aspirin 4.
Safety profile: Low-dose aspirin use until delivery is considered safe with no increased risk of placental abruption, postpartum hemorrhage, or neonatal bleeding complications in the evidence base 1, 2, 3.
Do not stop at arbitrary gestational ages: Some older protocols stopped at 35-36 weeks, but current evidence does not support this practice. The protective benefits for preeclampsia and thrombosis extend through the final weeks of pregnancy when risks remain elevated.